enGene Therapeutics Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2022 | — | $-19.4M | $-24.5M |
| FY2023 | — | $-26.1M | $-99.9M |
| FY2024 | — | $-62.3M | $-55.1M |
| FY2025 | — | $-123.2M | $-117.3M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2022 | — | $-19.4M | $-24.5M |
| FY2023 | — | $-26.1M | $-99.9M |
| FY2024 | — | $-62.3M | $-55.1M |
| FY2025 | — | $-123.2M | $-117.3M |